The injection or the injection? Restricted contraceptive choices among women living with HIV

listen audio

Study Justification:
– Historically, women living with HIV have faced biased advice from healthcare workers regarding contraception and childbearing.
– Antiretroviral therapy has made motherhood safer for women living with HIV, prompting a re-examination of contraceptive services.
– The study aims to assess whether contraceptive services enable women living with HIV to realize their reproductive intentions.
Study Highlights:
– High prevalence of injectable contraceptive use after birth (74%).
– Increasing post-partum duration leads to higher discontinuation rates of injectable contraception.
– Desire for another child remains stable despite method choice and use inconsistencies.
– Women frequently receive injectable contraception shortly after birth, even if they had previously chosen another method or no method.
– Contraceptive services in South Africa remain largely unchanged over time, limiting women’s ability to make autonomous contraceptive choices.
– High rates of contraceptive discontinuation increase the risk of unintended pregnancy.
Study Recommendations:
– Improve the quality of care in contraceptive services for women living with HIV.
– Increase access to a variety of contraceptive methods, including long-term and short-term options, hormonal and non-hormonal methods, and both female- and male-controlled methods.
– Provide comprehensive information and counseling on contraindications, risks, benefits, and side effects of different contraceptive methods.
– Foster positive and trusting provider-client relationships in healthcare settings.
– Address the inconsistency between women’s reproductive intentions and patterns of contraceptive use.
– Reduce contraceptive discontinuation rates to minimize the risk of unintended pregnancy.
Key Role Players:
– Healthcare providers and staff involved in contraceptive services for women living with HIV.
– Policy makers and government officials responsible for reproductive health policies and programs.
– Non-governmental organizations (NGOs) working in the field of HIV and reproductive health.
– Community leaders and advocates for women’s rights and reproductive autonomy.
Cost Items for Planning Recommendations:
– Training programs for healthcare providers to improve their knowledge and skills in contraceptive counseling and service provision.
– Development and dissemination of educational materials on contraceptive methods and their use.
– Implementation of monitoring and evaluation systems to assess the quality of care in contraceptive services.
– Awareness campaigns to promote reproductive rights and autonomy among women living with HIV.
– Research and data collection to monitor the impact of interventions and track progress in improving contraceptive services.

The strength of evidence for this abstract is 7 out of 10.
The evidence in the abstract is moderately strong. The study used a mixed-methods approach, collecting both quantitative and qualitative data, which provides a comprehensive understanding of the topic. The study sample size is relatively large (471 women) and includes longitudinal data collected over an 18-month period. The study also used a quality of care framework to assess the contraceptive services provided to women living with HIV. However, the abstract does not provide specific details about the statistical analysis conducted on the quantitative data, limiting the ability to assess the robustness of the findings. To improve the strength of the evidence, the abstract should include more information about the statistical methods used and the significance of the findings. Additionally, providing more context about the limitations of the study would enhance the overall quality of the evidence.

Historically, women living with HIV (WLWH) have been vulnerable to biased advice from healthcare workers regarding contraception and childbearing. However, antiretroviral therapy (ART) has made motherhood safer, prompting a re-examination of whether contraceptive services enable the realisation of WLWH’s reproductive intentions. We use longitudinal quantitative data on contraceptive choice and use, and childbearing intentions collected in (up to) six interviews between entry into antenatal care (ANC) and 18 months post-partum from a cohort of 471 ART-initiated WLWH in Cape Town, South Africa. Thirty-nine of these women were randomly selected for in-depth interview where they described experiences of contraception services and use. We find high prevalence of injectable contraceptive (IC) use after birth (74%). With increasing post-partum duration, greater proportions of women discontinue this method (at 18 months 21% were not using contraception), while desires for another child remain stable. We find little consistency between method choice and use: many women who elected to use the intrauterine device, sterilisation or oral contraceptives at first ANC visit are using IC after birth. Women commonly report receiving an IC shortly after birth, including those who had previously chosen to use another method or no method. Among WLWH, injectables dominated the contraceptive method mix. Despite a human rights-grounded policy and attempts to introduce new methods, contraceptive services in South Africa remain largely unchanged over time. Women are frequently unable to make autonomous contraceptive choices. Despite low desires for future pregnancy, we observed high rates of contraceptive discontinuation, resulting in heightened risk of unintended pregnancy.

We used the concept of “quality of care”20 as an underlying basis for the study in order to examine the extent to which contraceptive services are meeting the needs of WLWH. We used three out of the six dimensions outlined by Jain21 in their quality of care framework for family planning services: choice of contraceptive methods, information given to the user and provider–client relations. (The remaining three elements in this framework are the technical competence of providers, patient follow-up mechanisms and an appropriate constellation of family planning services). The framework outlines how contraceptive users should have access to long-term and short-term contraceptive methods, hormonal and non-hormonal methods and both female- and male-controlled methods. With regard to information and counselling, users should be given information about contraindications, risks, benefits and side effects of the various methods. The dimension of provider–client relations describes how users should feel trusting and positive about their interactions with healthcare staff.21 We examined the quality of care in terms of its impact upon women’s patterns of contraceptive use, as well as the extent to which women are able to realise their right to reproductive autonomy.22 This was a mixed-methods study that used quantitative data from the Maternal-Child Health Antiretroviral Therapy (MCH-ART) study (a randomised trial evaluating strategies for delivering HIV care and treatment services to pregnant and post-partum WLWH) and qualitative data from in-depth interviews conducted with a subset of women enrolled in the MCH-ART cohort. The MCH-ART study took place at the Midwife Obstetric Unit (MOU) at the Gugulethu Community Health Centre (CHC) in Cape Town, South Africa. The CHC serves a historically disadvantaged community with a high burden of HIV. Among women attending the CHC’s antenatal care (ANC) clinic in 2015, the HIV prevalence was 33%.23 The CHC has offered PMTCT services since 2001, and the vertical transmission rate is estimated to be 2–4%. The MCH-ART study and methods have been described in detail previously.24 Women were enrolled into the MCH-ART study if they were seeking ANC at the study clinic, were living with HIV and eligible to initiate ART. In order for them to be eligible for ongoing participation in the research post-partum, they needed to have initiated ART and be breastfeeding (the MCH-ART study also examined the effect of HIV care on breastfeeding practices). The study followed 471 women from their first ANC visit (enrolment took place between 20th March 2013 up to 3rd April 2014) until 18 months post-partum. In this research, we made use of data on contraceptive use and childbearing intentions collected during (up to) seven study visits, the first taking place at first ANC visit and the remaining six visits taking place over an 18-month post-partum period. These study visits took place separately from routine antenatal, postnatal or ART services at a large, primary-level antenatal and obstetric facility. Women participated in face-to-face interviews, where study staff administered standardised questionnaires. Data on demographic characteristics and intended future contraceptive use were collected at first ANC visit. Participants were permitted multiple responses to the question on intended future contraceptive use, which was designed to capture intentions to use dual protection (i.e. a hormonal method in combination with a barrier method). At each following visit in the post-partum period, women reported on current contraceptive use and childbearing intentions. From the contraceptive use data, we generated a variable that identified a woman’s current use of contraception that is classified in the following way: (i) none, (ii) injection (both the two-month and three-month options), (iii) IUD (either the hormonal or copper method), (iv) female sterilisation, (v) implant and (vi) oral contraceptive. Reporting of condom use as a contraceptive method was inconsistent, so we did not include these data. Childbearing intention was recorded using a 4-point scale measuring future desire, categorised as (i) unsure, (ii) definitely do not want to become pregnant in the future, (iii) may want to become pregnant in the future and (iv) definitely do want to become pregnant in the next 12 months. In order to understand women’s reproductive intentions and the relationship between reproductive intentions and patterns of contraceptive use, we examined the distribution of childbearing desires and corresponding patterns of contraceptive use at the six study visits. We then compared the percentage distribution of women’s intended method of contraception at first ANC visit with the percentage distribution of methods used at one week post-partum. This gave insight into the extent to which services are meeting women’s prenatal contraceptive intentions. We conducted 39 in-depth interviews with a subset of women who we randomly selected from the list of participants enrolled in the MCH-ART study (the audio recording of a 40th interview was faulty and could not be transcribed). These interviews took place between 12 and 29 months post-partum. During the interviews women were asked to describe their feelings about planning pregnancies, lifetime use of contraception and experiences getting contraception in clinics. We also asked questions about their pregnancy and childbearing history, their future childbearing intentions, and about HIV and its relationship with motherhood, although this data is not included in this research paper. All of the interviews were conducted in isiXhosa, away from the clinic to ensure that the respondents felt free to report any negative experiences that they may have had with healthcare workers. The interviews were recorded and then simultaneously translated and transcribed. We conducted a thematic analysis of the interview transcripts in NVivo. First, two members of the research team separately coded 10 transcripts. Both researchers worked independently to identify and highlight key concepts and ideas to build initial codes. Second, they both collaborated in revision, editing, renaming and regrouping of these early codes to form the final coding structure used for the main analysis. This final coding structure was used to code the remaining 29 interview transcripts. In addition to the creation of codes, we wrote analytic memos which recorded our ideas about patterns, categories, concepts and themes in the data.25 These further informed the analysis of the transcripts. Ethical clearance for this study was given by the University of Cape Town Human Research Ethics Committee and the Columbia University Institutional Review Board (IRB). All participants provided written informed consent prior to participation, and women participating in the qualitative component signed an additional consent for the in-depth interview.

N/A

Based on the provided description, here are some potential innovations that could improve access to maternal health:

1. Comprehensive Contraceptive Counseling: Implementing a comprehensive contraceptive counseling program that ensures women living with HIV receive unbiased and accurate information about all available contraceptive methods, including their benefits, risks, and side effects.

2. Diversifying Contraceptive Method Options: Expanding the range of contraceptive methods available to women living with HIV, including long-acting reversible contraceptives (LARCs) such as intrauterine devices (IUDs) and implants, to provide more choices and increase the likelihood of finding a method that aligns with their preferences and reproductive goals.

3. Strengthening Provider-Client Relations: Enhancing provider training and communication skills to foster trusting and positive interactions with women seeking contraceptive services. This includes promoting respectful and non-judgmental attitudes towards women’s reproductive choices and ensuring that women feel empowered to make autonomous decisions about their contraceptive use.

4. Integrating Contraceptive Services into HIV Care: Integrating contraceptive services into routine HIV care settings, such as antenatal care clinics and HIV treatment centers, to improve access and convenience for women living with HIV. This could involve training healthcare providers to offer comprehensive reproductive health services alongside HIV care, ensuring that women receive integrated and coordinated care.

5. Addressing Discontinuation Rates: Developing strategies to address high rates of contraceptive discontinuation among women living with HIV, including targeted counseling and support to address barriers and challenges that may contribute to discontinuation. This could involve regular follow-up visits, reminders, and tailored support to help women continue using their chosen contraceptive method effectively.

6. Community Engagement and Education: Conducting community engagement and education initiatives to raise awareness about the importance of contraception for women living with HIV and dispel myths and misconceptions. This could involve community workshops, peer support programs, and the distribution of educational materials to empower women with accurate information.

It is important to note that these recommendations are based on the information provided and may need to be tailored to the specific context and needs of the population being served.
AI Innovations Description
Based on the provided description, the recommendation to improve access to maternal health for women living with HIV is to enhance the quality of contraceptive services. This can be achieved by focusing on the following aspects:

1. Choice of contraceptive methods: Ensure that women living with HIV have access to a wide range of contraceptive options, including long-term and short-term methods, hormonal and non-hormonal methods, and both female- and male-controlled methods. This will allow them to make informed decisions based on their individual needs and preferences.

2. Information and counseling: Provide comprehensive and accurate information about the various contraceptive methods, including contraindications, risks, benefits, and side effects. This will empower women to make informed choices and address any concerns they may have.

3. Provider-client relations: Foster a trusting and positive relationship between healthcare providers and women living with HIV. This includes creating a supportive and non-judgmental environment where women feel comfortable discussing their reproductive intentions and accessing contraceptive services.

By addressing these aspects of quality of care, it is expected that women living with HIV will have improved access to a wider range of contraceptive methods, receive accurate information and counseling, and feel empowered to make autonomous contraceptive choices. This, in turn, can help reduce unintended pregnancies and improve maternal health outcomes for women living with HIV.
AI Innovations Methodology
Based on the provided description, here are some potential recommendations to improve access to maternal health for women living with HIV:

1. Improve access to a variety of contraceptive methods: Ensure that women living with HIV have access to a wide range of contraceptive methods, including long-term and short-term options, hormonal and non-hormonal methods, and both female- and male-controlled methods. This will allow them to make informed choices based on their individual needs and preferences.

2. Enhance information and counseling services: Provide comprehensive information about the various contraceptive methods, including contraindications, risks, benefits, and side effects. Ensure that healthcare providers are trained to provide accurate and non-biased information to women living with HIV, enabling them to make informed decisions about their reproductive health.

3. Strengthen provider-client relations: Foster trusting and positive interactions between healthcare staff and women living with HIV. This can be achieved through training healthcare providers to be empathetic, respectful, and non-judgmental, creating a safe and supportive environment for women to discuss their reproductive health needs.

To simulate the impact of these recommendations on improving access to maternal health, a methodology could be developed as follows:

1. Define the indicators: Identify key indicators that measure access to maternal health, such as contraceptive use rates, contraceptive method mix, contraceptive discontinuation rates, and women’s satisfaction with contraceptive services.

2. Collect baseline data: Gather data on the current state of access to maternal health services for women living with HIV. This can be done through surveys, interviews, and medical records review.

3. Implement the recommendations: Introduce the recommended interventions, such as improving access to contraceptive methods, enhancing information and counseling services, and strengthening provider-client relations.

4. Monitor and evaluate: Continuously collect data on the identified indicators to assess the impact of the interventions. This can be done through follow-up surveys, interviews, and tracking of contraceptive use and discontinuation rates.

5. Analyze the data: Use statistical analysis techniques to compare the baseline data with the data collected after implementing the recommendations. This will help determine the extent to which access to maternal health has improved.

6. Draw conclusions and make recommendations: Based on the analysis of the data, draw conclusions about the impact of the interventions on improving access to maternal health for women living with HIV. Identify any gaps or areas for further improvement and make recommendations for future interventions.

7. Iterate and refine: Use the findings from the evaluation to refine the interventions and iterate the process, if necessary, to further improve access to maternal health services for women living with HIV.

By following this methodology, policymakers and healthcare providers can gain insights into the effectiveness of the recommended interventions and make informed decisions to improve access to maternal health for women living with HIV.

Share this:
Facebook
Twitter
LinkedIn
WhatsApp
Email